tiprankstipranks
Algernon Pharmaceuticals (AGNPF)
OTHER OTC:AGNPF
US Market

Algernon Pharmaceuticals (AGNPF) Income Statement

Compare
72 Followers

Algernon Pharmaceuticals Income Statement

Last quarter (Q4 2024), Algernon Pharmaceuticals's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Algernon Pharmaceuticals's net income was C$-421.43K. See Algernon Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Gross Profit
C$ -50.40KC$ -34.94KC$ 0.00C$ 0.00C$ -27.00K
Operating Expenses
C$ 5.24MC$ 6.06MC$ 8.05MC$ 8.68MC$ 1.91M
Depreciation and Amortization
C$ 50.40KC$ 34.94KC$ 7.88MC$ 27.00KC$ 27.00K
EBITDA
C$ -4.98MC$ -6.02MC$ 0.00C$ -8.54MC$ -1.87M
Operating Income
C$ -5.02MC$ -6.06MC$ -8.05MC$ -8.76MC$ -1.93M
Other Income/Expenses
C$ -1.76MC$ 63.27KC$ 2.11MC$ 858.46KC$ 29.96K
Pretax Income
C$ -6.78MC$ -6.05MC$ -7.73MC$ -8.54MC$ -1.90M
Net Income
C$ -6.78MC$ -6.05MC$ -7.72MC$ -8.42MC$ -1.88M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.45C$ -0.73C$ -1.04C$ -2.00C$ -0.88
Diluted EPS
C$ -0.45C$ -0.73C$ -1.04C$ -2.00C$ -0.88
Weighted Average Shares Outstanding
15.15M 8.30M 7.44M 4.21M 2.13M
Weighted Average Shares Outstanding (Diluted)
15.15M 8.30M 7.44M 4.21M 2.13M
Currency in CAD

Algernon Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis